Women with healthy BMI may have higher risk of breast cancer

April 5, 2017 by Heather Lindsey, Cornell University
Women with healthy BMI may have higher risk of breast cancer
Inflamed breast fat with crown-like structures comprised of immune cells (brown) surrounding fat cell (white). Credit: Weill Cornell Medicine/Memorial Sloan Kettering Cancer Center

Women with a healthy body mass index (BMI) may be at risk of developing breast cancer because of enlarged fat cells in their breast tissue that trigger an inflammatory process, according to a new study from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers.

When these fat cells, or adipocytes, become excessively large, "they can become sick or die, setting off an inflammatory reaction," said senior study author Dr. Andrew Dannenberg, the Henry R. Erle, M.D.-Roberts Family Professor of Medicine and associate director of at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. This inflammation is associated with molecular changes in the breast and blood, which are known to increase the risk of .

For their study, published March 7 in Cancer Prevention Research, the researchers evaluated fat tissue from the breast and blood samples of 72 patients with normal BMIs – a measure of weight and height defined as less than 25 – who were undergoing mastectomies as a risk-reduction procedure or . They found that 39 percent of women had inflammation of their breast fat tissue.

While doctors often consider an obese patient's risk, they may not automatically think about the risk of malignancy when an individual has a normal BMI, said study lead author Dr. Neil Iyengar, a medical oncologist in the Breast Medicine Service at Memorial Sloan Kettering Cancer Center and an assistant professor of medicine at Weill Cornell Medicine. This research "increases our awareness of a potentially vulnerable population," Iyengar said. "An alarming number of people may be at risk."

Some women with a normal BMI may have an increased amount of body fat "manifesting itself as enlarged adipocytes, predisposing them to inflammation," Dannenberg said. The enlarged sick or dying adipocytes release substances into fat tissue and blood, helping to recruit white blood cells called macrophages that cause inflammation. The macrophages that envelop the dying adipocytes form crown-like structures that reflect inflammation. While "these macrophages eat the dead or sick adipocyte and clear it," the inflammatory process that is likely to contribute to cancer has already begun, Dannenberg said.

Specifically, the researchers found that breast inflammation was associated with an elevation of the enzyme aromatase. Aromatase helps make estrogen, which can encourage the growth of some hormone-sensitive breast tumors.

In addition, they measured high levels of metabolic markers such as insulin and glucose in these patients. "It is similar to prediabetes, which is traditionally considered to be associated with overweight or obesity," Iyengar said. "We call it metabo-inflammation, which means there's inflammation in the fat that has metabolic consequences even in these normal weight women." Prior research has shown that insulin and glucose increase and shorten survival of women with the disease.

Based on the current study, the investigators are now assessing body composition using a dual-energy X-ray absorptiometry (DEXA) scan, typically used to measure bone density, and trying to determine whether increased body fat or blood biomarkers might identify women with healthy BMIs who have underlying inflamed fat.

"If we can develop a noninvasive test to identify those with inflamed fat," Dannenberg said, "we will be positioned to reduce the risk of cancer."

Once diagnosed, the goal is to offer interventions such as diet and exercise that may influence and metabolic health, Iyengar said. Future research is needed to answer the question of why people with healthy BMIs develop this inflammatory state. "We don't currently know the precise reasons," Iyengar said, "but it will be important to examine diet and activity levels to see if any patterns emerge and to ultimately develop effective cancer prevention and treatment strategies."

Explore further: Breast density research edges closer to cancer prevention

Related Stories

Breast density research edges closer to cancer prevention

January 24, 2017
Adelaide researchers are one step closer to breast cancer prevention after finding a new driver for breast density, an identified risk factor for breast cancer.

ASCO: BMI, menopause status linked to breast inflammation

September 5, 2014
(HealthDay)—Body mass index (BMI) and postmenopausal status are independently associated with breast white adipose tissue (WAT) inflammation, according to a study scheduled to be presented at the American Society of Clinical ...

Researchers quantify immune cells associated with future breast cancer risk

February 8, 2017
Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.

Research links obesity to poor survival in tongue cancer patients

February 5, 2014
(Medical Xpress)—Cancer experts from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College are working side by side to unravel the mysterious link between obesity and cancer. Most recently, their collaborative ...

Obesity associated with increased breast cancer risk in postmenopausal women

June 11, 2015
An analysis of extended follow-up data from the Women's Health Initiative clinical trials suggests that postmenopausal women who were overweight and obese had an increased risk of invasive breast cancer compared to women ...

Breast cancer awareness: What women need to know

September 28, 2016
As national Breast Cancer Awareness Months begins next week, breast health expert Dr. Sharon Koehler of New York Institute of Technology College of Osteopathic Medicine, says women need to know the following five things:

Recommended for you

Pancreatic cancer's addiction could be its end

November 13, 2018
Cancer cells are often described as cells "gone bad" or "renegade." New research reveals that in some of the deadliest cases of pancreatic cancer, these rebellious cells have an unexpected addiction. Now, scientists are investigating ...

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

Study finds promising therapeutic target for aggressive type of breast cancer

November 13, 2018
A new Nature Communications study led by University of Kentucky Markey Cancer Center researchers suggests that an enzyme known as Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) is a potential therapeutic target for triple negative ...

Scientists shine new light on link between obesity and cancer

November 12, 2018
Scientists have made a major discovery that shines a new, explanatory light on the link between obesity and cancer. Their research confirms why the body's immune surveillance systems—led by cancer-fighting Natural Killer ...

Obesity both feeds tumors and helps immunotherapy kill cancer

November 12, 2018
A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.